Loading...
Population Pharmacokinetics, Pharmacodynamics, and Exploratory Exposure–Response Analyses of Apixaban in Subjects Treated for Venous Thromboembolism
Apixaban is approved for treatment of venous thromboembolism (VTE) and prevention of recurrence. Population pharmacokinetics, pharmacokinetics–pharmacodynamics (anti‐FXa activity), and exposure–response (binary bleeding and thromboembolic endpoints) of apixaban in VTE treatment subjects were charact...
Na minha lista:
| Udgivet i: | CPT Pharmacometrics Syst Pharmacol |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5445237/ https://ncbi.nlm.nih.gov/pubmed/28547774 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/psp4.12184 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|